Navigation Links
The ribosome -- a new target for antiprion medicines
Date:7/2/2013

New research results from Uppsala University, Sweden, show that the key to treating neurodegenerative prion diseases such as mad cow disease and Creutzfeldt-Jakob disease may lie in the ribosome, the protein synthesis machinery of the cell. The results were recently published in the Journal of Biological Chemistry.

Prion diseases are fatal neurodegenerative diseases caused by misfolding of prion proteins. Examples of prion diseases are scrapie in sheep, mad cow disease and Creutzfeldt-Jakob disease in human.

What triggers misfolding of the prion proteins to the amyloid disease form is an open question. The inadequate knowledge in the field about the factors involved in prion formation makes the discovery of effective medicines for prion diseases rather challenging.

"We have now shown that the protein folding activity of the ribosome (PFAR) is most likely involved in prion propagation and thus, can be a specific target for antiprion medicines. If we understand the mechanism fully, we will be able to find ways to stop that too.", says Suparna Sanyal, senior lecturer at the Department of Cell and Molecular Biology, Uppsala University .

The ribosome is the protein synthesis machinery of the cell. The mechanism of protein synthesis by the ribosome is well characterized, while PFAR is a rather recent discovery. PFAR is a ribosomal RNA dependent function of the large subunit of the ribosome irrespective of its source. The PFAR center closely overlaps the peptidyl transferase center although the nucleobases responsible for these two functions are not all common.

"Our results show that two prion inhibitors 6-aminophenanthridine and guanabenz acetate implement antiprion activity by binding to ribosomal RNA and inhibiting PFAR. Thus, the ribosome and more specifically PFAR is the new target for antiprion medicines. Furthermore, we have developed an in vitro PFAR assay, which can be used as a platform for screening pri
'/>"/>

Contact: Suparna Sanyal
suparna.sanyal@icm.uu.se
46-184-714-220
Uppsala University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mimicking living cells: Synthesizing ribosomes
2. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
3. Major rethink needed if chemical industry is to meet greenhouse gas targets
4. Powerful gene-editing tool appears to cause off-target mutations in human cells
5. Breakthrough research of essential molecule reveals important targets in diabetes and obesity
6. Scientists identify potential drug target for treatment-resistant anemias
7. Singapore research team identifies new drug target in deadly form of leukemia
8. MU researchers develop radioactive nanoparticles that target cancer cells
9. U of M researchers develop model for better testing, targeting of MPNST
10. SUMO wrestling cells reveal new protective mechanism target for stroke
11. Study identifies possible new acute leukemia marker, treatment target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... role of sensors and associated instrumentation technologies has ... stringent and sophisticated, requiring innovative development of sensor ... achieve these market demands. Novel tools, techniques and ... will be smaller, have increased sensitivity, require specific ...
... January 21, 2010 The bubbles in your champagne that ... are exhibiting a behavior quite similar to the tiny bubbles found ... But while the champagne bubbles are likely to raise ... and affect the climate. "Bubbles are little packets of gases ...
... A new study published in CMAJ ( Canadian ... severity of H1N1 influenza has found that admissions to ... longer interval between symptom onset and treatment with antivirals ... of First Nations ethnicity were also found to be ...
Cached Biology News:Conference to discuss future of nanotechnology enabled sensors 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 3Disease severity in H1N1 patients 2
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 According to ... ÔÇťAgricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... USD 15,300 million in 2012 and is expected to ... CAGR of 9.5% from 2013 to 2019. , ...
(Date:2/26/2015)... Feb. 26, 2015  Epic Sciences announced today that ... present at the 35th Annual Cowen and Company Health ... the MIT Room, 3rd Floor. The conference will be ... Mass. Epic is developing diagnostic tests of ... and proteomic changes that occur during the course of ...
(Date:2/26/2015)... 26, 2015 Caris Life Sciences® today ... 2015 Genitourinary Cancers Symposium in Orlando, ... of tumor profiling. Both studies utilized Caris Molecular ... to identify biomarkers that shed light on potential ... cell bladder cancer (SCBC). In ...
Breaking Biology Technology:More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5
... announces that a new market research report is ... Discovery Techniques and Applications – A Global Market ... `A more focused discovery process using proteins ... the development stage for quite some time now. ...
... Calif., Sept. 21 TOPICA Pharmaceuticals, Inc. a privately-held ... a sublicense and purchase option agreement with an undisclosed ... the skin in the Americas and Europe. By agreement, ... In conjunction with the sublicensing agreement, TOPICA Pharmaceuticals ...
... NEW YORK and JERUSALEM, Sept. 21 Chiasma, ... Chiasma,s Chairman & CEO, will present an overview of the ... Grand Hyatt, New York, New York, on Wednesday, September 22, ... conducting its second clinical trial of the investigational new drug ...
Cached Biology Technology:Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 2Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 3Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 4Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 5Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 6Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 7Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 8Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 9Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 10Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 11Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 12Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 13Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 14Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 15Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 16Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 17TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication 2Chiasma to Present at the UBS Global Life Sciences Conference 2Chiasma to Present at the UBS Global Life Sciences Conference 3
lid holder -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... integrated digital microscope and camera system that ... optical adjustment or software installation. Built on ... combines simplicity and advanced technology for users ... viewing of a macro image and a ...
Biology Products: